Table 2.
Types | Matrix | Preparation Methods | Characteristic | Ref. |
---|---|---|---|---|
Physically cross-linked cyclodextrin-containing hydrogels | Chitosan | Casting method | Bilayer hydrogels | [48] |
Chitosan | Freeze-thaw cycling method | pH sensitivity | [49] | |
Chitosan | Freezing method | Thermosensitive; Shortly gelation time (3 min or less) | [50] | |
Chitosan/Poly(Vinyl Alcohol) | Dry at room temperature in vacuo | pH-specific release behavior | [51] | |
Gellan gum | Gelation at room temperature | Biocompatible material | [52] | |
Hydroxypropyl methylcellulose | Dispersion method | Benefit for skin | [53] | |
Nanocellulose | 30 min with autoclaving (121 ℃, 103 kPa) | Sustained release | [54] | |
poly (vinyl alcohol) | Freezing drying method | Long-term release | [55] | |
Soy soluble polysaccharide | Reduced pressure and stored in a desiccator | 3D-nanocomposites, superabsorbent, malleable, bioadhesive | [56] | |
Xanthan | Freezing drying method | Long-term release | [57] | |
Chemically cross-linked cyclodextrin-containing hydrogels | 4-arm-Polyethylene glycol-Succinimidyl Glutarate | Nucleophilic substitution-based method | Improved the therapeutic effect |
[58] |
Agarose gel | Nucleophilic substitution-based method | Low gelling temperature for controlled drug delivery |
[59] | |
Carboxymethyl cellulose | Free radical polymerization crosslinking-based method | pH-responsive behaviour | [60] | |
Carboxymethyl cellulose | Nucleophilic substitution-based method | Biocompatible, capable of controlling the release for a long duration | [61] | |
Chitosan | Nucleophilic substitution-based method | Local antibiotic release | [62] | |
Nanocellulose | Nucleophilic substitution-based method | Cell compatibility, non-cytotoxicity | [63] | |
Polyvinyl alcohol |
Nucleophilic substitution-based method | Good strength, elasticity, WVP, and swelling ability | [64] | |
Poly(N-isopropylacrylamide) | Free radical polymerization crosslinking-based method | Thermoresponsive | [65] | |
Poly(2-hydroxyethyl methacrylate) | Nucleophilic substitution-based method | Sustained drug delivery |
[66] | |
Sodium hyaluronan | Nucleophilic substitution-based method | Controlled release | [67] |